Your browser doesn't support javascript.
loading
Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
Qin, Caipeng; Sheng, Zhengzuo; Huang, Xinmei; Tang, Jingshu; Liu, Yang; Xu, Tao; Qiu, Xiaoyan.
Affiliation
  • Qin C; Department of Urology, Peking University People's Hospital, Beijing, China.
  • Sheng Z; Department of Urology, Peking University People's Hospital, Beijing, China.
  • Huang X; Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing, China.
  • Tang J; Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing, China.
  • Liu Y; Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing, China.
  • Xu T; Department of Urology, Peking University People's Hospital, Beijing, China.
  • Qiu X; Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing, China.
Prostate ; 80(13): 1134-1144, 2020 09.
Article in En | MEDLINE | ID: mdl-32628304

Full text: 1 Database: MEDLINE Main subject: Immunoglobulin G / SOXB1 Transcription Factors / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Immunoglobulin G / SOXB1 Transcription Factors / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Year: 2020 Type: Article